Abstract
Background Although a growing number of primary total hip arthroplasties (THAs) are being performed on solid-organ transplant (SOT) recipients, long-term patient and implant survivorships have not been well studied in contemporary transplant and arthroplasty practices. Methods A total of 136 THAs (105 patients) with prior SOT were retrospectively reviewed from 2000 to 2013 at mean clinical follow-up of 5 years. The mean age was 59 years, with 39% being females. The most common SOT was renal (56%), followed by liver (24%). Results Patient mortality was 3.8% and 13.3% at 2 and 5 years, respectively. There were 9 revisions (6.6%), including 5 (4%) for deep periprosthetic infection. Implant survivorship free of any revision was 95% and 94% at 2 and 5 years, respectively. Transplant type or surgical indication did not significantly impact patient or implant survivorship. Conclusion Compared with the general population, SOT patients undergoing THA have slightly higher mortality rates at 5 years. Implant survivorship free of revision was slightly lower than the general population, primarily due to an increased risk of periprosthetic joint infection.
Original language | English (US) |
---|---|
Pages (from-to) | 2525-2529 |
Number of pages | 5 |
Journal | Journal of Arthroplasty |
Volume | 31 |
Issue number | 11 |
DOIs | |
State | Published - Nov 1 2016 |
Keywords
- deep periprosthetic joint infection
- solid-organ transplant
- survivorship
- total hip arthroplasty
ASJC Scopus subject areas
- Orthopedics and Sports Medicine